Saturday, July 03, 2010

Which US Pharma are Sanofi buying for $20 billion?

The options market played host to a number of speculative and bullish trades in Genzyme, Biogen Idec and Botox maker Allergan amid reports that a French drug maker may pursue a major U.S. acquisition.

No comments: